In the context of aspergillosis, macrophages depend on enhanced glucose metabolism, driven by the activation of mammalian target of rapamycin (mTOR) and hypoxia-inducible factor-1α (HIF-1α), to support their antifungal effector activity (97). This evidence concerns the gene MTOR and aspergillosis.